Cargando…
Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry
BACKGROUND: Recent publications reported a paradoxical finding that there was an inverse association between the number of standard modifiable risk factors (SMuRFs; smoking, hypertension, diabetes, and hyperlipidemia) and mortality in patients with myocardial infarction. However, the current evidenc...
Autores principales: | Li, Sidong, Gao, Xiaojin, Yang, Jingang, Xu, Haiyan, Wang, Yang, Zhao, Yanyan, Yin, Lu, Wu, Chao, Wang, Yi, Zheng, Yang, Li, Bao, Zhang, Xuan, Ye, Yunqing, Fu, Rui, Dong, Qiuting, Sun, Hui, Yan, Xinxin, Wu, Yuan, Zhang, Jun, Jin, Chen, Li, Wei, Yang, Yuejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258075/ https://www.ncbi.nlm.nih.gov/pubmed/35790971 http://dx.doi.org/10.1186/s12916-022-02418-w |
Ejemplares similares
-
Current Status and Hospital-Level Differences in Care and Outcomes of Patients With Acute Non-ST-Segment Elevation Myocardial Infarction in China: Insights From China Acute Myocardial Infarction Registry
por: Zhao, Qinghao, et al.
Publicado: (2022) -
Length of Stay and Short-Term Outcomes in Patients with ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: Insights from the China Acute Myocardial Infarction Registry
por: Lv, Junxing, et al.
Publicado: (2021) -
Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry
por: Lv, Junxing, et al.
Publicado: (2023) -
The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry
por: Peiyuan, He, et al.
Publicado: (2016) -
Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry
por: Wu, Chao, et al.
Publicado: (2023)